| Valid Data Submission Method(s) | Measure Type | High Priority Measure? | NQS Domain | Specialty Measure Sets |
|---|---|---|---|---|
| Registry | Process | No | Effective Clinical Care |
Measure Description
Percentage of patients aged 18 years and older with a diagnosis of multiple myeloma, not in remission, who were prescribed or received intravenous bisphosphonate therapy within the 12 month reporting period
Instruction
This measure is to be reported a minimum of once per performance period for all multiple myeloma (not in remission) patients seen during the performance period. It is anticipated that eligible clinicians who provide services for the patients with the diagnosis of multiple myeloma (not in remission) will submit this measure.
Denominator
All patients aged 18 years and older with a diagnosis of multiple myeloma, not in remission
Denominator Criteria (Eligible Cases):
Patients aged ≥ 18 years on date of encounter
AND
Diagnosis for multiple myeloma – not in remission (ICD-10-CM): C90.00, C90.02
AND
Patient encounter during the performance period (CPT): 99201, 99202, 99203, 99204, 99205,
99212, 99213, 99214, 99215
WITHOUT
Telehealth Modifier: GQ, GT
Numerator
Patients who were prescribed or received intravenous bisphosphonate therapy within the 12 month reporting period
Definitions:
Bisphosphonate Therapy – Includes the following medications: pamidronate and zoledronate. Prescribed – Includes patients who are currently receiving medication(s) that follow the treatment plan recommended at an encounter during the performance period, even if the prescription for that medication was ordered prior to the encounter.
Numerator Options:
Performance Met: Bisphosphonate therapy, intravenous, ordered or received (4100F)
OR
Denominator Exception: Documentation of medical reason(s) for not prescribing bisphosphonates (eg, patients who do not have bone disease, patients with dental disease, patients with renal insufficiency) (4100F with 1P)
OR
Denominator Exception: Documentation of patient reason(s) for not prescribing
bisphosphonates (4100F with 2P)
OR
Performance Not Met: Bisphosphonate therapy, intravenous, not
ordered or ceived, reason not otherwise specified (4100F with
8P)